Composition: Each tablet contains Chloroquine Phosphate B.P. 250 mg (equivalent to Chloroquine, base 155 mg)

Indications: Treatment of acute malaria caused by Plasmodium malariae, P. vivax and P. ovalae and susceptible strains of P. falciparum. Prophylaxis of malaria for non-immuned individuals at risk. Rheumatoid arthritis and lupus erythematosus.

Presentation:
Bottle of 60 ml
1 blister of 10 tablets each per pack
Jar of 1000 tablets